Close Menu

NEW YORK – Abbott Laboratories announced Thursday that its Architect SARS-CoV-2 IgG antibody test received Health Canada authorization and that it will begin shipping antibody tests to Canada this week. 

The serology blood test detects IgG antibodies that identify whether a patient has had COVID-19 and runs on Abbott's Architect i1000SR and i2000SR instruments, which can run up to 100 to 200 tests an hour. The test will expand to the Alinity i system and Abbott hopes to expand serology testing to include testing for IgM antibodies in the future, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.